Related Experiment Videos
[Invasive treatment methods in therapy and angiogenic sepsis]
Terapevticheskii Arkhiv
|January 1, 1987
Summary
Vascular access device infections, including sepsis, occurred in 0.43% of patients. Staphylococcus aureus was identified as the primary cause of angiogenic sepsis, necessitating improved prevention strategies.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Medicine
Context:
- Vascular access devices like catheters, shunts, and fistulas are crucial in patient care.
- Infection associated with these devices poses a significant clinical challenge.
- Understanding the microbial etiology and clinical presentation of device-related infections is essential.
Purpose:
- To investigate the incidence of sepsis in patients with vascular access devices.
- To identify microorganisms responsible for device-related infections and sepsis.
- To describe the clinical features, diagnosis, and prevention of angiogenic sepsis.
Summary:
- Sepsis developed in 0.43% of 1850 patients with vascular access devices.
- Catheter and shunt infections were more common than sepsis.
- Bacteriological analysis of 300 catheters revealed microbial growth in 27.7%, with Staphylococcus aureus identified as the cause of angiogenic sepsis.
Impact:
- Highlights the importance of monitoring and preventing infections associated with vascular access devices.
- Provides insights into the clinical manifestations and early diagnostic signs of angiogenic sepsis.
- Emphasizes the need for effective strategies for the pathogenesis and prevention of angiogenic sepsis.